1. Home
  2. HLX vs EYPT Comparison

HLX vs EYPT Comparison

Compare HLX & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HLX
  • EYPT
  • Stock Information
  • Founded
  • HLX 1979
  • EYPT 1987
  • Country
  • HLX United States
  • EYPT United States
  • Employees
  • HLX N/A
  • EYPT N/A
  • Industry
  • HLX Oilfield Services/Equipment
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • Sector
  • HLX Energy
  • EYPT Industrials
  • Exchange
  • HLX Nasdaq
  • EYPT Nasdaq
  • Market Cap
  • HLX 928.9M
  • EYPT 967.4M
  • IPO Year
  • HLX 1997
  • EYPT 2005
  • Fundamental
  • Price
  • HLX $6.59
  • EYPT $14.13
  • Analyst Decision
  • HLX Strong Buy
  • EYPT Strong Buy
  • Analyst Count
  • HLX 2
  • EYPT 5
  • Target Price
  • HLX $10.50
  • EYPT $29.60
  • AVG Volume (30 Days)
  • HLX 1.7M
  • EYPT 1.4M
  • Earning Date
  • HLX 10-22-2025
  • EYPT 11-05-2025
  • Dividend Yield
  • HLX N/A
  • EYPT N/A
  • EPS Growth
  • HLX 497.36
  • EYPT N/A
  • EPS
  • HLX 0.28
  • EYPT N/A
  • Revenue
  • HLX $1,312,445,000.00
  • EYPT $42,339,000.00
  • Revenue This Year
  • HLX N/A
  • EYPT N/A
  • Revenue Next Year
  • HLX $4.96
  • EYPT N/A
  • P/E Ratio
  • HLX $23.15
  • EYPT N/A
  • Revenue Growth
  • HLX N/A
  • EYPT N/A
  • 52 Week Low
  • HLX $5.52
  • EYPT $3.91
  • 52 Week High
  • HLX $11.48
  • EYPT $14.91
  • Technical
  • Relative Strength Index (RSI)
  • HLX 48.61
  • EYPT 64.75
  • Support Level
  • HLX $6.42
  • EYPT $11.30
  • Resistance Level
  • HLX $6.82
  • EYPT $12.22
  • Average True Range (ATR)
  • HLX 0.23
  • EYPT 1.08
  • MACD
  • HLX -0.03
  • EYPT 0.23
  • Stochastic Oscillator
  • HLX 31.71
  • EYPT 90.19

About HLX Helix Energy Solutions Group Inc.

Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. the Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Share on Social Networks: